Cline Scientific

July - December 2022

• Net sales amounted to 0 (0) SEK.
• Operating profit amounted to 237,140 (-143,519) SEK
• Profit per average number of shares after tax amounted to 0.01 (-0.01)

January - December 2022

• Net sales amounted to 0 (3,991) SEK.
• Operating profit amounted to -2,317,061 (-3,503,694) SEK
• Profit per average number of shares after tax amounted to -0.15 (-0.24)

The report is published at www.clinescientific.com/financial-reports

 The company is listed on the Nasdaq First North Growth Market. Redeye AB is Cline Scientific's Certified Adviser. The information was submitted for publication via the contact person listed above, at 8.30am CET on 17 February 2023.

For more information, please contact:

Patrik Sundh, CEO

Email: patrik.sundh@clinescientific.com

Phone: +46 703-585 088